The global market for portable CPR is expected to gain momentum in the coming years on account of the awareness amongst people about cardiac disorders. The advancements in healthcare infrastructure across the globe has been a significant propeller of market growth. CPR (Cardiopulmonary Resuscitation) is a process under which the chest in perpetually compressed and retracted while giving rescue breaths to an individual suffering a cardiac arrest. A report by Transparency Market Research (TMR) analyses several factors prevalent in the global market for portable CPR and gives a comprehensive purview of the market. The report is titled ‘Portable CPR Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025’.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26675
The need for emergency medical services (EMS) has created tremendous opportunities for growth within the market. Since cardiac arrests can be fatally dangerous, the healthcare fraternity has been making ardent efforts to provide quality clinical services. This has given an impetus to the market while growth spaces for market players. The high instance of cardiovascular diseases coupled with the technological advancements in healthcare has provided a launch pad for the market to propel. However, the heavy costs of CPR devices in conjunction with low skill of the medical professional’s hampers market growth. The efforts of the governments to provide better healthcare infrastructure can help resolve the problems prevailing in the market.
The global market for portable CPR can be regionally segmented into the Middle East and Africa, North America, Europe, Latin America, and Asia Pacific. The market in North America is expected to emerge as the leading market over the coming years. The supremacy of the regional market owes to the prominence of the healthcare infrastructure in U.S. and Canada.
Some of the key market vendors include Physio-Control Inc., St. Jude Medical, Revivant Corp., Koninklijke Philips N.V., and Cardiac Science Corporation.